OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Improving global vaccine accessibility
Andrew B. Hill, Christopher Kilgore, Margaret G. McGlynn, et al.
Current Opinion in Biotechnology (2016) Vol. 42, pp. 67-73
Closed Access | Times Cited: 44

Showing 1-25 of 44 citing articles:

Escherichia coli-derived virus-like particles in vaccine development
Xiaofen Huang, Xin Wang, Jun Zhang, et al.
npj Vaccines (2017) Vol. 2, Iss. 1
Open Access | Times Cited: 128

Stabilizing vaccines via drying: Quality by design considerations
Zahra Ghaemmaghamian, Reza Zarghami, Gavin Walker, et al.
Advanced Drug Delivery Reviews (2022) Vol. 187, pp. 114313-114313
Open Access | Times Cited: 53

How Sugars Protect Dry Protein Structure
Julia A. Brom, Ruta G. Petrikis, Gary J. Pielak
Biochemistry (2023) Vol. 62, Iss. 5, pp. 1044-1052
Open Access | Times Cited: 40

Novel technology for storage and distribution of live vaccines and other biological medicines at ambient temperature
Irnela Bajrovic, Stephen C. Schafer, Dwight K. Romanovicz, et al.
Science Advances (2020) Vol. 6, Iss. 10
Open Access | Times Cited: 65

Thermostable vaccines: an innovative concept in vaccine development
Ravinder Kumar, Vartika Srivastava, Piyush Baindara, et al.
Expert Review of Vaccines (2022) Vol. 21, Iss. 6, pp. 811-824
Closed Access | Times Cited: 37

Biomimetic metal-organic frameworks as protective scaffolds for live-virus encapsulation and vaccine stabilization
Ruhani Singh, John White, Malisja de Vries, et al.
Acta Biomaterialia (2022) Vol. 142, pp. 320-331
Open Access | Times Cited: 33

Nanostructured Temperature Indicator for Cold Chain Logistics
Anastasiya G. Navrotskaya, Darya D. Aleksandrova, Mahshid Chekini, et al.
ACS Nano (2022) Vol. 16, Iss. 6, pp. 8641-8650
Closed Access | Times Cited: 33

Understanding dry proteins and their protection with solid‐state hydrogen–deuterium exchange
Julia A. Brom, Gary J. Pielak
Protein Science (2025) Vol. 34, Iss. 3
Closed Access

Biological and physicochemical stability assessment of a nanostructured vaccine formulation
Federico N.Ruiz Moreno, Constanza Marín, Nicolás D. Dho, et al.
Journal of Drug Delivery Science and Technology (2025), pp. 106940-106940
Closed Access

Spray dried cubosomes with ovalbumin and Quil-A as a nanoparticulate dry powder vaccine formulation
Christoffer von Halling Laier, Blake Gibson, Marco van de Weert, et al.
International Journal of Pharmaceutics (2018) Vol. 550, Iss. 1-2, pp. 35-44
Open Access | Times Cited: 36

From Protection to Prevention: Redefining Vaccines in the Context of Antimicrobial Resistance
Mohammed Sallam, Johan Snygg, Doaa Allam, et al.
Cureus (2024)
Open Access | Times Cited: 3

Ensilication Improves the Thermal Stability of the Tuberculosis Antigen Ag85b and an Sbi-Ag85b Vaccine Conjugate
Ayla A. Wahid, Aswin Doekhie, Asel Sartbaeva, et al.
Scientific Reports (2019) Vol. 9, Iss. 1
Open Access | Times Cited: 29

Protection by desiccation‐tolerance proteins probed at the residue level
Candice J. Crilly, Julia A. Brom, Owen A. Warmuth, et al.
Protein Science (2021) Vol. 31, Iss. 2, pp. 396-406
Open Access | Times Cited: 20

Dried Protein Structure Revealed at the Residue Level by Liquid-Observed Vapor Exchange NMR
Candice J. Crilly, Julia A. Brom, Mark E. Kowalewski, et al.
Biochemistry (2021) Vol. 60, Iss. 2, pp. 152-159
Open Access | Times Cited: 18

Equivalence of freeze-dried and liquid-frozen formulations of MVA-BN as smallpox and mpox vaccine
Richard N. Greenberg, Darja Schmidt, Daniela Reichhardt, et al.
Human Vaccines & Immunotherapeutics (2024) Vol. 20, Iss. 1
Open Access | Times Cited: 2

Cold Chain Management by Healthcare Providers at a District in Ghana: A Mixed Methods Study
Anthoniette Asamoah, Nancy Innocentia Ebu Enyan, Abigail Kusi‐Amponsah Diji, et al.
BioMed Research International (2021) Vol. 2021, pp. 1-12
Open Access | Times Cited: 17

Drying of Vaccines and Biomolecules
Bhaskar N. Thorat, Ayantika Sett, Arun S. Mujumdar
Drying Technology (2020) Vol. 40, Iss. 3, pp. 461-483
Closed Access | Times Cited: 17

Lyophilized yeast powder for adjuvant free thermostable vaccine delivery
Ravinder Kumar, Bhushan N. Kharbikar
Applied Microbiology and Biotechnology (2021) Vol. 105, Iss. 8, pp. 3131-3143
Open Access | Times Cited: 13

Standardization and Key Aspects of the Development of Whole Yeast Cell Vaccines
Anna Jéssica Duarte Silva, Crislaine Kelly da Silva Rocha, Antônio Carlos de Freitas
Pharmaceutics (2022) Vol. 14, Iss. 12, pp. 2792-2792
Open Access | Times Cited: 9

Evaluation of the effects of spray drying parameters for producing cubosome powder precursors
Christoffer von Halling Laier, Tommy Sonne Alstrøm, Mia Travers Bargholz, et al.
European Journal of Pharmaceutics and Biopharmaceutics (2018) Vol. 135, pp. 44-48
Open Access | Times Cited: 16

Evaluation of the thermal stability of live-attenuated Rubella vaccine (Takahashi strain) formulated and lyophilized in different stabilizers
Somayeh Shokri, Mohammad Kazem Shahkarami, A. Shafyi, et al.
Journal of Virological Methods (2018) Vol. 264, pp. 18-22
Closed Access | Times Cited: 14

Protecting Lyophilized Escherichia coli Adenylate Kinase
Julia A. Brom, Ruta G. Petrikis, Grace E. Nieukirk, et al.
Molecular Pharmaceutics (2024) Vol. 21, Iss. 7, pp. 3634-3642
Closed Access | Times Cited: 1

Page 1 - Next Page

Scroll to top